FDA Drug recall D-0334-2020
Viatrexx-Infla, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0279, NDC 73069-249-41
- FDA Drug
- Class II
- terminated
- Published 2019-11-20
On 2019-11-20 the FDA classified a Class II recall of Viatrexx-Infla, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0279, NDC 73069-249-41 by 8046255 Canada, citing lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0334-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-10-15 |
| Published | 2019-11-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | 8046255 Canada |
| Distribution | US |
Product
Viatrexx-Infla, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0279, NDC 73069-249-41.
Reason
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Identifiers
| code_info | Lot Numbers: 19-S00012, Exp. May: 2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0334-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.